99 related articles for article (PubMed ID: 25047250)
1. Twice-daily pill could treat leukemia.
Printz C
Cancer; 2014 Aug; 120(15):2225. PubMed ID: 25047250
[No Abstract] [Full Text] [Related]
2. Idelalisib Bolsters CLL Regimen.
Leslie M
Cancer Discov; 2016 Mar; 6(3):OF2. PubMed ID: 26772993
[No Abstract] [Full Text] [Related]
3. Chemoimmunotherapy in chronic lymphocytic leukemia.
Stilgenbauer S
Clin Adv Hematol Oncol; 2010 Dec; 8(12):867-8. PubMed ID: 21326163
[No Abstract] [Full Text] [Related]
4. Rituximab-containing therapy for chronic lymphocytic leukaemia.
Tanimoto T; Sakiyama M; Hori A; Yagasaki F; Kami M
Lancet; 2011 Jan; 377(9761):205; author reply 206. PubMed ID: 21237394
[No Abstract] [Full Text] [Related]
5. Rituximab-containing therapy for chronic lymphocytic leukaemia.
Haines I; Elliott P; Stanley R
Lancet; 2011 Jan; 377(9761):205; author reply 206. PubMed ID: 21237393
[No Abstract] [Full Text] [Related]
6. Idelalisib improves CD37 antibody BI 836826 cytotoxicity against chemo-resistant /relapse-initiating CLL cells: a rationale for combination treatment.
Betrian S; Ysebaert L; Heider KH; Delord JP; Fournié JJ; Quillet-Mary A
Blood Cancer J; 2016 Nov; 6(11):e496. PubMed ID: 27834943
[No Abstract] [Full Text] [Related]
7. CLL2-BXX Phase II trials: sequential, targeted treatment for eradication of minimal residual disease in chronic lymphocytic leukemia.
Cramer P; von Tresckow J; Bahlo J; Engelke A; Langerbeins P; Fink AM; Fischer K; Wendtner CM; Kreuzer KA; Stilgenbauer S; Böttcher S; Eichhorst B; Hallek M
Future Oncol; 2018 Mar; 14(6):499-513. PubMed ID: 29465308
[TBL] [Abstract][Full Text] [Related]
8. The efficacy and stem cell toxicity of cladribine and rituximab in the treatment of patients with chronic lymphocytic leukemia: are all purine analogs created equal?
Tadmor T; Polliack A; Tam CS
Leuk Lymphoma; 2010 Apr; 51(4):571-3. PubMed ID: 20141447
[No Abstract] [Full Text] [Related]
9. Idelalisib-related pneumonitis.
Haustraete E; Obert J; Diab S; Abbes S; Zini JM; Valade S; Lerolle N; Albin N; Arnulf B; Bouaziz JD; Hussenet C; Tazi A; Bergeron A
Eur Respir J; 2016 Apr; 47(4):1280-3. PubMed ID: 26917607
[No Abstract] [Full Text] [Related]
10. Idelalisib--a PI3Kδ inhibitor for B-cell cancers.
Fruman DA; Cantley LC
N Engl J Med; 2014 Mar; 370(11):1061-2. PubMed ID: 24620870
[No Abstract] [Full Text] [Related]
11. Obinutuzumab looks impressive in CLL.
Cancer Discov; 2014 Apr; 4(4):OF5. PubMed ID: 24706674
[No Abstract] [Full Text] [Related]
12. Chemoimmunotherapy of chronic lymphocytic leukemia.
Tam CS; Keating MJ
Best Pract Res Clin Haematol; 2007 Sep; 20(3):479-98. PubMed ID: 17707835
[TBL] [Abstract][Full Text] [Related]
13. Chronic lymphocytic leukemia with nuclear budding.
Huang JZ; Folbe MH; Richards SK; Kolins MD
Eur J Haematol; 2012 Jan; 88(1):92. PubMed ID: 21801234
[No Abstract] [Full Text] [Related]
14. PI3K-δ inhibitor produces long-lasting responses.
Cancer Discov; 2013 Jul; 3(7):OF11. PubMed ID: 23847354
[TBL] [Abstract][Full Text] [Related]
15. Rituximab plus fludarabine and cyclophosphamide or other agents in chronic lymphocytic leukemia.
Robak T; Lech-Maranda E; Robak P
Expert Rev Anticancer Ther; 2010 Oct; 10(10):1529-43. PubMed ID: 20942624
[TBL] [Abstract][Full Text] [Related]
16. [Current concepts in chronic lymphocytic leukemia. Better chances for young patients].
Hallek M; Bergmann M; Goede V; Fingerle-Rowson G; Schweighofer C; Schmitt B; Wendtner CM; Emmerich B
MMW Fortschr Med; 2003 Jul; 145(27-28):46-9. PubMed ID: 14587189
[No Abstract] [Full Text] [Related]
17. Monoclonal antibodies in chronic lymphocytic leukemia.
Ferrajoli A; Faderl S; Keating MJ
Expert Rev Anticancer Ther; 2006 Sep; 6(9):1231-8. PubMed ID: 17020457
[TBL] [Abstract][Full Text] [Related]
18. Treatment options for newly diagnosed patients with chronic lymphocytic leukemia.
Erba HP
Curr Hematol Rep; 2004 Jan; 3(1):47-53. PubMed ID: 14695850
[TBL] [Abstract][Full Text] [Related]
19. Agranulocytosis occurring in a patient with chronic lymphocytic leukemia in complete remission; treatment by rituximab and cyclosporin.
Costello RT; Sébahoun G
Leuk Res; 2010 Dec; 34(12):e329-30. PubMed ID: 20723978
[No Abstract] [Full Text] [Related]
20. [Specific palatal infiltration in B-cell chronic lymphocytic leukemia].
Cervigón I; Palomo A; Torres-Iglesias LM; Solano F; Zapata AM
Actas Dermosifiliogr; 2011 May; 102(4):305-7. PubMed ID: 21354544
[No Abstract] [Full Text] [Related]
[Next] [New Search]
